IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$423.65 USD
-6.17 (-1.44%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $423.84 +0.19 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$423.65 USD
-6.17 (-1.44%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $423.84 +0.19 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Zacks News
MedTech Stocks to Top Q2 Estimates
by Zacks Equity Research
Most of the MedTech majors are lined up to report their earnings results over the next week.
What's in the Offing for Hologic (HOLX) in Q3 Earnings?
by Zacks Equity Research
Hologic's (HOLX) gain through product launch and Cynosure integration may get hampered by a dull Cytology performance.
IDEXX Laboratories (IDXX) Q2 Earnings: A Beat in the Cards?
by Zacks Equity Research
IDEXX Laboratories' (IDXX) Companion Animal Group business might drive its performance in Q2.
DENTSPLY SIRONA Renews Canadian Distribution Agreement
by Zacks Equity Research
DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced the renewal of an existing distribution agreement with Henry Schein Canada, Inc.
Luminex Gets CE Mark for ARIES Norovirus Assay, Shares Rally
by Zacks Equity Research
Shares of Luminex Corporation (LMNX) gained 1.5% to close at $21.38 after the company announced the receipt of CE-IVD mark for the ARIES Norovirus Assay.
IDEXX Well-Poised on Strong Fundamentals, Global Growth
by Zacks Equity Research
On 29, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
CryoLife Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Leading medical device and tissue processing company, CryoLife, Inc. (CRY) rallied to a new 52-week high of $20.20 on Jun 27, eventually closing a little lower at $19.65.
Medidata (MDSO), inVentiv Enter Into Multi-Year Partnership
by Zacks Equity Research
Medidata Solutions Inc. (MDSO) recently announced that it has entered into a multi-year partnership with inVentiv Health, a leading biopharmaceutical professional services company.
Merit Medical Embosphere Gets FDA de novo Classification
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres from the FDA to expand its indication in the prostatic artery embolization (PAE) space.
Evolent Health (EVH) Prices 4.5M Follow-On Share Offering
by Zacks Equity Research
Evolent Health, Inc. (EVH) recently announced the pricing of its follow-on public offering of 4.5 million shares of Class A common stock at $25.90 per share.
PRA Health Hits a 52-Week High on Strategic Acquisitions
by Zacks Equity Research
Leading global contract research organization PRA Health Sciences (PRAH) rallied to a new 52-week high of $78.30 on Jun 21, closing a little lower at $77.21.
Luminex (LMNX) Banks on Portfolio Strength, View Impressive
by Zacks Equity Research
On Jun 21, we issued an updated research report on Austin, TX-based Luminex Corp (LMNX) -- a manufacturer and marketer of proprietary biological testing technologies with applications throughout the life sciences and diagnostics industry.
Medidata Solutions (MDSO) Set to Join the S&P 400 Index
by Zacks Equity Research
Medidata Solutions Inc. (MDSO), a leading global provider of clinical development solutions, is scheduled to join the coveted S&P 400 benchmark before the opening bell on Jun 26.
PRA Health (PRAH) Shares Rally on Partnership with Jumo
by Zacks Equity Research
Shares of PRA Health (PRAH) rallied 2.3% to close at $75.50, following PRA Health's recently announced partnership with Jumo, a global provider of educational health care information.
Neogen Offers NeoSeek Genomic Services to Ensure Food Safety
by Zacks Equity Research
Headquartered in Lansing, MI, Neogen Corporation (NEOG) recently announced the availability of next generation sequencing services for the food industry.
DENTSPLY (XRAY) Renews Partnership with Pacific Dental
by Zacks Equity Research
DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced that it has renewed its strategic partnership with Pacific Dental Services, LLC.
Pacific Biosciences (PACB) Prices Offering of Common Stock
by Zacks Equity Research
Pacific Biosciences of California, Inc. (PACB) recently announced that it has priced its underwritten public offering of 15.4 million shares of its common stock.
Varian Showcases Halcyon System at DEGRO Meet, Stock Up
by Zacks Equity Research
Shares of Varian Medical Systems Inc. (VAR) rallied almost 1% after the company showcased a new Halcyon radiotherapy treatment system at the 2017 DEGRO meeting, the German radiation oncology society, in Berlin.
TransEnterix Sells Surgery System to Japanese University
by Zacks Equity Research
TransEnterix, Inc. (TRXC), a global medical technology company, recently announced that it has sold a Senhance Robotic Surgery System to a Japanese customer.
Baxter-Dorizoe Ink Deal to Expand Generic Injectables Line
by Zacks Equity Research
Deerfield, IL-based Baxter International Inc. (BAX), a global medical technology company, recently signed an agreement with India-based Dorizoe Lifesciences for expansion of its generic injectables pipeline.
CONMED (CNMD) Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Shares of Utica, NY-based leading medical technology player, CONMED Corporation (CNMD) rallied to a new 52-week high of $52.79 on Jun 13, closing a little lower at $52.49.
5 Top Performing Efficient Stocks to Buy Now
by Tirthankar Chakraborty
A favorable efficiency level provides impressive returns as it is positively correlated with the company's price performance
IDEXX Laboratories Global Growth Solid amid Currency Woes
by Zacks Equity Research
On May 29, we issued an updated research report on leading molecular diagnostic company, IDEXX Laboratories, Inc. (IDXX).
IDEXX (IDXX) Up 3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
IDEXX (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IDEXX Laboratories (IDXX) Raised to Buy on Solid Prospects
by Zacks Equity Research
On May 22, IDEXX Laboratories, Inc. (IDXX), a leading manufacturer of products and services primarily for the companion animal veterinary, was raised by a notch to a Zacks Rank #2 (Buy).